Integration of mechanistic data in the toxicological evaluation of endocrine modulators.
Controversy has arisen concerning the likelihood of adverse health effects due to exposure to hormonally active agents or endocrine modulators such as environmental estrogens. With the aim to improve the basis for their toxicological evaluation, several chemicals of anthropogenic (bisphenol A, octylphenol, o,p'-DDT) and of natural origin (daidzein, genistein) were investigated with regard to their mode of hormonal action and potency as well as toxicokinetics. Experimental toxicodynamic and toxicokinetic data illustrate important points in a comparative assessment of environmental estrogens. A novel concept, the Hygiene-Based Margine of Safety (HBMOS), has been suggested to characterize the relative impact of these potential endocrine modulators on human health: It integrates exposure scenarios (i.a. those generated within the European Existing Chemicals Programme) and in vivo rodent potency data for xenoestrogens and for dietary phytoestrogens. On the basis of these informations, HBMOS values calculated for the alkylphenol and bisphenol A appear sufficiently high to ensure the absence of a practical risk to human health under the present exposure conditions. For slowly accumulating compounds (e.g. DDT) with much longer half-lifes than isoflavones, such comparison should be based on comparative blood levels rather than on scenarios of daily exposures.
Degen
Gisela H
GH
Institute of Occupational Physiology (IfADo), University of Dortmund, Ardeystr. 67, Germany. degen@ifado.de
Janning
Petra
P
Wittsiepe
Jürgen
J
Upmeier
Andreas
A
Bolt
Hermann M
HM
D000818:Animals; D001681:Biological Assay / Q000379:methods; D004703:Endocrine System / Q000187:drug effects*; D004781:Environmental Exposure / Q000009:adverse effects; D004968:Estrogens, Non-Steroidal / Q000009:adverse effects / Q000633:toxicity; D006727:Hormone Antagonists / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000633:toxicity; D006801:Humans; D014018:Tissue Distribution; D015262:Xenobiotics / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000633:toxicity
D004968:Estrogens, Non-Steroidal; D006727:Hormone Antagonists; D015262:Xenobiotics